These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25892313)

  • 1. Enterobacteriaceae resistant to third generation cephalosporins upon hospital admission: risk factors and clinical outcomes.
    Oliveira MC; Oliveira CR; Gonçalves KV; Santos MS; Tardelli AC; Nobre VA
    Braz J Infect Dis; 2015; 19(3):239-45. PubMed ID: 25892313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India.
    Bharadwaj R; Robinson ML; Balasubramanian U; Kulkarni V; Kagal A; Raichur P; Khadse S; Kadam D; Valvi C; Kinikar A; Kanade S; Suryavanshi N; Marbaniang I; Nelson G; Johnson J; Zenilman J; Sachs J; Gupta A; Mave V
    BMC Infect Dis; 2018 Oct; 18(1):504. PubMed ID: 30286741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High rates of antimicrobial co-resistance among Enterobacteriaceae: comparative analysis between clinical isolates resistant and susceptible to third-generation cephalosporins.
    Goyanes MJ; Cercenado E; Insa R; Morente A; Alcalá L; Bouza E
    Rev Esp Quimioter; 2007 Jun; 20(2):216-21. PubMed ID: 17893759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological situation of enterobacteriaceae resistant to cephalosporins third generation in the region of Mahdia, Tunisia (2002-2014).
    Majdoub A; Ben Hadj Kalifa A; Bannour I; Meksi Y; Ouaz M; Kheder M
    Tunis Med; 2018; 96(8-9):483-489. PubMed ID: 30430525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of diagnostic prediction tools for bacteraemia caused by third-generation cephalosporin-resistant enterobacteria in suspected bacterial infections: a nested case-control study.
    Rottier WC; van Werkhoven CH; Bamberg YRP; Dorigo-Zetsma JW; van de Garde EM; van Hees BC; Kluytmans JAJW; Kuck EM; van der Linden PD; Prins JM; Thijsen SFT; Verbon A; Vlaminckx BJM; Ammerlaan HSM; Bonten MJM
    Clin Microbiol Infect; 2018 Dec; 24(12):1315-1321. PubMed ID: 29581056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for third-generation cephalosporin resistant Enterobacteriaceae in gestational urine cultures: A retrospective cohort study based on centralized electronic health records.
    Guri A; Flaks-Manov N; Ghilai A; Hoshen M; Flidel Rimon O; Ciobotaro P; Zimhony O
    PLoS One; 2020; 15(1):e0226515. PubMed ID: 31899777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nursing home residents and Enterobacteriaceae resistant to third-generation cephalosporins.
    Sandoval C; Walter SD; McGeer A; Simor AE; Bradley SF; Moss LM; Loeb MB
    Emerg Infect Dis; 2004 Jun; 10(6):1050-5. PubMed ID: 15207056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for colonization with third-generation cephalosporin-resistant enterobacteriaceae.
    Wendt C; Lin D; von Baum H
    Infection; 2005 Oct; 33(5-6):327-32. PubMed ID: 16258862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor clinical outcomes associated with community-onset urinary tract infections due to extended-spectrum cephalosporin-resistant Enterobacteriaceae.
    Anesi JA; Lautenbach E; Nachamkin I; Garrigan C; Bilker WB; Omorogbe J; Dankwa L; Wheeler MK; Tolomeo P; Han JH;
    Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1431-1435. PubMed ID: 30375298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study.
    Anesi JA; Lautenbach E; Nachamkin I; Garrigan C; Bilker WB; Omorogbe J; Dankwa L; Wheeler M; Tolomeo P; Han JH;
    BMC Infect Dis; 2019 Feb; 19(1):163. PubMed ID: 30764770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors.
    Hamprecht A; Rohde AM; Behnke M; Feihl S; Gastmeier P; Gebhardt F; Kern WV; Knobloch JK; Mischnik A; Obermann B; Querbach C; Peter S; Schneider C; Schröder W; Schwab F; Tacconelli E; Wiese-Posselt M; Wille T; Willmann M; Seifert H; Zweigner J;
    J Antimicrob Chemother; 2016 Oct; 71(10):2957-63. PubMed ID: 27317445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals.
    von Baum H; Lin D; Wendt C
    Clin Microbiol Infect; 2004 May; 10(5):436-40. PubMed ID: 15113322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of Multidrug-Resistant Organisms Cultured From Urine of Children Undergoing Clean Intermittent Catheterization.
    Forster CS; Courter J; Jackson EC; Mortensen JE; Haslam DB
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):332-338. PubMed ID: 29186590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional study on fecal carriage of Enterobacteriaceae with resistance to extended-spectrum cephalosporins in primary care patients.
    Nüesch-Inderbinen MT; Abgottspon H; Zurfluh K; Nüesch HJ; Stephan R; Hächler H
    Microb Drug Resist; 2013 Oct; 19(5):362-9. PubMed ID: 23611297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the therapeutic efficacies of third-generation cephalosporins and broader-spectrum β-lactams as appropriate empirical therapy in adults with community-onset monomicrobial Enterobacteriaceae bacteraemia: a propensity score matched analysis.
    Lee CH; Hsieh CC; Hong MY; Hung YP; Ko WC; Lee CC
    Int J Antimicrob Agents; 2017 May; 49(5):617-623. PubMed ID: 28315452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
    Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
    Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Admission prevalence of colonization with third-generation cephalosporin-resistant Enterobacteriaceae and subsequent infection rates in a German university hospital.
    Boldt AC; Schwab F; Rohde AM; Kola A; Bui MT; Märtin N; Kipnis M; Schröder C; Leistner R; Wiese-Posselt M; Zweigner J; Gastmeier P; Denkel LA
    PLoS One; 2018; 13(8):e0201548. PubMed ID: 30067833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality associated with third generation cephalosporin-resistance in Enterobacteriaceae infections: a multicenter cohort study in Southern China.
    Wang J; Zhou M; Hesketh T; Kritsotakis EI
    Expert Rev Anti Infect Ther; 2021 Nov; 19(11):1481-1487. PubMed ID: 33836130
    [No Abstract]   [Full Text] [Related]  

  • 20. High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals.
    Rohde AM; Wiese-Posselt M; Zweigner J; Schwab F; Mischnik A; Seifert H; Gastmeier P; Kern WV;
    J Antimicrob Chemother; 2018 Jun; 73(6):1688-1691. PubMed ID: 29490046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.